These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24699006)

  • 1. Glucose as an agent of post-translational modification in diabetes--New cardiac epigenetic insights.
    Mellor KM; Brimble MA; Delbridge LM
    Life Sci; 2015 May; 129():48-53. PubMed ID: 24699006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of O-GlcNAcylation in nutritional sensing, insulin resistance and in mediating the benefits of exercise.
    Myslicki JP; Belke DD; Shearer J
    Appl Physiol Nutr Metab; 2014 Nov; 39(11):1205-13. PubMed ID: 25203141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-translational modifications disclose a dual role for redox stress in cardiovascular pathophysiology.
    Victorino VJ; Mencalha AL; Panis C
    Life Sci; 2015 May; 129():42-7. PubMed ID: 25433127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [O-GlcNAc glycosylation and regulation of cell signaling].
    Issad T
    Med Sci (Paris); 2010; 26(8-9):753-9. PubMed ID: 20819714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impairment of calcium ATPases by high glucose and potential pharmacological protection.
    Horáková L; Strosova MK; Spickett CM; Blaskovic D
    Free Radic Res; 2013 Aug; 47 Suppl 1():81-92. PubMed ID: 23710650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-GlcNAcylation, an original modulator of contractile activity in striated muscle.
    Cieniewski-Bernard C; Montel V; Stevens L; Bastide B
    J Muscle Res Cell Motil; 2009 Dec; 30(7-8):281-7. PubMed ID: 20182775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAc modification, insulin signaling and diabetic complications.
    Issad T; Masson E; Pagesy P
    Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of insulin action by advanced glycation endproducts: a new player in the field.
    Schalkwijk CG; Brouwers O; Stehouwer CD
    Horm Metab Res; 2008 Sep; 40(9):614-9. PubMed ID: 18792872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aging induces cardiac diastolic dysfunction, oxidative stress, accumulation of advanced glycation endproducts and protein modification.
    Li SY; Du M; Dolence EK; Fang CX; Mayer GE; Ceylan-Isik AF; LaCour KH; Yang X; Wilbert CJ; Sreejayan N; Ren J
    Aging Cell; 2005 Apr; 4(2):57-64. PubMed ID: 15771609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the role of maladaptive hexosamine biosynthesis and O-GlcNAcylation in development of diabetic cardiac complications.
    Qin CX; Sleaby R; Davidoff AJ; Bell JR; De Blasio MJ; Delbridge LM; Chatham JC; Ritchie RH
    Pharmacol Res; 2017 Feb; 116():45-56. PubMed ID: 27988387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergence of glucose- and fatty acid-induced abnormal myocardial excitation-contraction coupling and insulin signalling.
    Davidoff AJ
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):152-8. PubMed ID: 16445715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial insulin resistance, metabolic stress and autophagy in diabetes.
    Mellor KM; Bell JR; Ritchie RH; Delbridge LM
    Clin Exp Pharmacol Physiol; 2013 Jan; 40(1):56-61. PubMed ID: 22804725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes.
    Tchaikovski V; Olieslagers S; Böhmer FD; Waltenberger J
    Circulation; 2009 Jul; 120(2):150-9. PubMed ID: 19564559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo.
    Vasan S; Zhang X; Zhang X; Kapurniotu A; Bernhagen J; Teichberg S; Basgen J; Wagle D; Shih D; Terlecky I; Bucala R; Cerami A; Egan J; Ulrich P
    Nature; 1996 Jul; 382(6588):275-8. PubMed ID: 8717046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute insulin resistance mediated by advanced glycation endproducts in severely burned rats.
    Zhang X; Xu J; Cai X; Ji L; Li J; Cao B; Li J; Hu D; Li Y; Wang H; Xiong L; Xiao R; Gao F
    Crit Care Med; 2014 Jun; 42(6):e472-80. PubMed ID: 24670938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGE-induced interference of glucose uptake and transport as a possible cause of insulin resistance in adipocytes.
    Wu CH; Huang HW; Huang SM; Lin JA; Yeh CT; Yen GC
    J Agric Food Chem; 2011 Jul; 59(14):7978-84. PubMed ID: 21650468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of advanced glycation end products in diabetes-associated cardiovascular and renal disease.
    Cooper ME
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):31S-38S. PubMed ID: 15607433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
    Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
    Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O-GlcNAc modification in diabetes and Alzheimer's disease.
    Dias WB; Hart GW
    Mol Biosyst; 2007 Nov; 3(11):766-72. PubMed ID: 17940659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.